| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
10,716 |
10,593 |
$1.72M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,658 |
5,609 |
$1.36M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,165 |
3,118 |
$443K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,016 |
1,008 |
$360K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,163 |
477 |
$222K |
| J3490 |
Unclassified drugs |
5,751 |
4,327 |
$191K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,371 |
1,365 |
$140K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,118 |
2,052 |
$113K |
| 80053 |
Comprehensive metabolic panel |
3,413 |
3,379 |
$75K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
925 |
907 |
$67K |
| 71045 |
Radiologic examination, chest; single view |
2,773 |
2,756 |
$38K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,561 |
5,498 |
$34K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
717 |
715 |
$31K |
| 64493 |
|
50 |
26 |
$19K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
201 |
201 |
$19K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
979 |
964 |
$16K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
53 |
53 |
$12K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
263 |
257 |
$11K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
152 |
152 |
$8K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,538 |
1,511 |
$8K |
| 81001 |
|
2,677 |
2,660 |
$7K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
319 |
319 |
$7K |
| 84484 |
|
406 |
386 |
$6K |
| 83735 |
|
752 |
747 |
$4K |
| 81025 |
|
532 |
531 |
$4K |
| 83690 |
|
563 |
557 |
$3K |
| 87400 |
|
210 |
137 |
$3K |
| 70450 |
Computed tomography, head or brain; without contrast material |
61 |
61 |
$3K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
13 |
13 |
$2K |
| 80050 |
General health panel |
64 |
64 |
$2K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
16 |
15 |
$2K |
| 80061 |
Lipid panel |
210 |
210 |
$2K |
| 82805 |
|
18 |
18 |
$1K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
12 |
12 |
$928.40 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
146 |
146 |
$867.03 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
13 |
13 |
$718.51 |
| 84443 |
Thyroid stimulating hormone (TSH) |
72 |
72 |
$715.46 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
25 |
24 |
$618.35 |
| 83880 |
|
13 |
12 |
$419.04 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
27 |
27 |
$367.50 |
| 84703 |
|
51 |
51 |
$334.50 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
12 |
12 |
$252.12 |
| 36415 |
Collection of venous blood by venipuncture |
100 |
99 |
$216.27 |
| 85610 |
|
56 |
54 |
$194.82 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
486 |
459 |
$156.16 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
387 |
380 |
$145.79 |
| 84702 |
|
14 |
12 |
$143.26 |
| 87070 |
|
12 |
12 |
$84.04 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
80 |
79 |
$66.53 |
| 81003 |
|
33 |
33 |
$62.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
834 |
823 |
$1.59 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
50 |
50 |
$1.48 |
| J7050 |
Infusion, normal saline solution, 250 cc |
13 |
12 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
51 |
50 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
13 |
13 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
45 |
41 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
18 |
16 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
12 |
12 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
12 |
12 |
$0.00 |